Victory Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.8M Sell
1,703,200
-61,027
-3% -$711K 0.01% 878
2025
Q1
$13.1M Buy
1,764,227
+1,746,571
+9,892% +$13M 0.01% 953
2024
Q4
$106K Sell
17,656
-409
-2% -$2.45K ﹤0.01% 2332
2024
Q3
$92.5K Sell
18,065
-308
-2% -$1.58K ﹤0.01% 2333
2024
Q2
$66.5K Sell
18,373
-299
-2% -$1.08K ﹤0.01% 2340
2024
Q1
$59.9K Sell
18,672
-415
-2% -$1.33K ﹤0.01% 2362
2023
Q4
$93.5K Buy
19,087
+3,509
+23% +$17.2K ﹤0.01% 2351
2023
Q3
$84.9K Buy
15,578
+209
+1% +$1.14K ﹤0.01% 2323
2023
Q2
$103K Sell
15,369
-358
-2% -$2.4K ﹤0.01% 2302
2023
Q1
$139K Sell
15,727
-164
-1% -$1.45K ﹤0.01% 2314
2022
Q4
$121K Sell
15,891
-6
-0% -$46 ﹤0.01% 2336
2022
Q3
$113K Sell
15,897
-1,087
-6% -$7.73K ﹤0.01% 2454
2022
Q2
$137K Buy
16,984
+3,166
+23% +$25.5K ﹤0.01% 2416
2022
Q1
$114K Buy
13,818
+267
+2% +$2.2K ﹤0.01% 2497
2021
Q4
$380K Sell
13,551
-15,065
-53% -$422K ﹤0.01% 2297
2021
Q3
$973K Sell
28,616
-436
-2% -$14.8K ﹤0.01% 1875
2021
Q2
$1.19M Buy
29,052
+1,448
+5% +$59.2K ﹤0.01% 1832
2021
Q1
$1.11M Sell
27,604
-28,017
-50% -$1.13M ﹤0.01% 1871
2020
Q4
$3.29M Sell
55,621
-5,010
-8% -$296K ﹤0.01% 1359
2020
Q3
$2.95M Sell
60,631
-8,048
-12% -$391K ﹤0.01% 1323
2020
Q2
$3.32M Sell
68,679
-268,899
-80% -$13M ﹤0.01% 1274
2020
Q1
$9.38M Buy
337,578
+261,172
+342% +$7.26M 0.01% 1103
2019
Q4
$2.29M Sell
76,406
-11,604
-13% -$347K ﹤0.01% 1454
2019
Q3
$2.72M Buy
88,010
+27,010
+44% +$835K ﹤0.01% 1348
2019
Q2
$2.95M Buy
+61,000
New +$2.95M 0.01% 1043